VFC Program: 9-valent HPV Vaccine

Beginning July 1, 2015, the Philadelphia Vaccines For Children (VFC) Program will move over entirely to supplying the recently licensed recommended 9-valent human papillomavirus (9vHPV) GARDASIL®9 vaccine to replace the currently supplied 4-valent human papillomavirus (4vHPV) GARDASIL®4 vaccine. Both vaccines are manufactured by Merck, Sharpe and Dohme Corp.

2014 New Year Immunization Update

This Immunization Update includes information on: Updated 2014 Immunization Schedule, HPV Project Reminder/Recall, Short-Dated Vaccine Policy Changes, Storage and Handling Updates: Data Loggers; Dual Units; Policy Changes, Twice Annual AFIX Assessments, New VFC/VFAAR and KIDS Enrollment Forms Due June 2014, Screen for Insurance at Every Immunization Visit, New Immunization Program Manual.